investors.taminco.com

investors.symmetrysurgical.com

Overview | Symmetry Surgical

Code of Business Conduct and Ethics. About Our Clinical Education Team. Grants and Educational Support. Bookwalter and Greenberg Checkups. Stock Quote and Chart. Q2 2015 Investor Presentation. Q2 2015 Symmetry Surgical Inc Earnings Conference Call. 160;at 8:00 am ET. Q2 2015 Symmetry Surgical Inc Earnings Conference Call. Thursday, August 6, 2015 . 8:00 am ET  . Click here for webcast. Click here to add this event to your calendar. Symmetry Surgical Inc at JMP Securities Life Sciences Conference. Shop th...

investors.synchronyfinancial.com

Investors | Synchrony Financial

Skip to main content. Careers - We're Hiring. Synchrony Financial Investor Relations. Synchrony Financial Investor Relations. Synchrony Financial brings 80 years of experience and financial leadership under a new name, offering private label credit cards, promotional financing options, FDIC-insured savings products and more. Check the schedule to join our next webcast and view content from our past events. Check the current stock price, charts and other historical data. For Fixed Income Investors:. It lo...

investors.syneron.com

Investor Relations - Syneron Medical Ltd. (NASDAQ: ELOS) - Overview

For an overview of all our products. Skin Brightening - elure. Photo Rejuvenation and Treatment of Dyschromia. Circumferential Reduction and Cellulite Treatment. For an overview of all our treatments. For an overview of all our products. For an overview of all our treatments. Investor Relations Syneron Medical Ltd (ELOS) IR Room. Syneron Medical Ltd. (NASDAQ: ELOS). Is a leading global aesthetic device company with a comprehensive product portfolio and a global distribution footprint. Syneron Medical Rep...

investors.tableau.com

Tableau Software - Investor Relations

The stock information provided is for informational purposes only and is not intended for trading purposes. The Stock Information and Stock Chart is provided by TickerTech, a third party service, and Tableau Software does not maintain or provide information directly to this service. Stock information is delayed approximately 20 minutes. 08 Aug, 2013 @. Tableau Software 2nd Quarter 2013 Earnings Conference Call. View the live Webcast. View the Press Release. 12 Aug, 2013 @. View the live Webcast.

investors.tactilemedical.com

Investor Overview - Tactile Medical

Flexitouch Mechanism of Action. Flexitouch User Guide and Indications. Entré User Guide and Indications. Adaptive Compression Therapy System. ACTitouch Mechanism of Action. ACTitouch User Guide and Indications. Venous Leg Ulcer Studies. Commercial Insurance Order Process. Veterans Affairs Order Process. Medicare Order Process Venous Leg Ulcers. Medicare Order Process Lymphedema. Warranty and Return Policies. Stock Quote and Chart. 160;- 0.44. January 12, 20174:00 pm ET. Q3 2016 Investor Presentation.

investors.taminco.com

Taminco Investor Relations - Corporate Profile

Taminco at a Glance. Submit your Invention, Idea or Solution. Dec 5, 2014. Eastman Completes Acquisition of Taminco. Nov 6, 2014. Taminco Corporation Announces Third Quarter 2014 Results. Oct 27, 2014. Taminco Corporation Announces Third Quarter 2014 Earnings Release Date and Conference Call. No events to display. Taminco Corporation Q3 2014 Earnings Presentation - November 6, 2014. Taminco Corporation Quarterly Income Statement - Q4. Annual Meeting and Proxy Materials. Tweets by @taminco 1.

investors.tangeroutlet.com

Tanger Outlets | Investor Relations | Corporate Profile

Atlantic City, New Jersey. Blowing Rock, North Carolina. Charleston, South Carolina. Deer Park, New York. Fort Myers, Florida. Hilton Head, South Carolina. Lincoln City, Oregon. Locust Grove, Georgia. Mebane, North Carolina. Myrtle Beach - Hwy 17, SC. Myrtle Beach - Hwy 501, SC. Nags Head, North Carolina. Ocean City, Maryland. Park City, Utah. Rehoboth Beach, Delaware. Riverhead, New York. San Marcos, Texas. Tilton, New Hampshire. West Branch, Michigan. Wisconsin Dells, Wisconsin. Myrtle Beach - Hwy 17.

investors.target.com

Investors | Investor Contacts, News, Stocks & Events | | Target Corporate

Skip to main navigation. A Bullseye View. Behind the scenes at Target. MBAs and graduate degrees. News and features expand. News and features home. Target embraces innovation to drive strong financial performance and create new opportunities for profitable growth. 160; 0.56. Dividend and stock split history. Statement from Brian Cornell Regarding Kathee Tesija Transition. CVS Health and Target Sign Agreement for CVS Health to Acquire, Rebrand and Operate Target’s Pharmacies and Clinics.

investors.targovax.com

Investor Relations | Targovax

Skip to main content. Adenovirus-based cancer immunotherapies: ONCOS-102, ONCOS-402. Peptide-based targeted immunotherapies: TG01, TG02 and TG03. Listing on the Oslo Axess. Subscribe to our news. Targovax is an innovation driven specialist in immuno-oncology. Immunotherapy is a fast growing segment within the biotech market, estimated by analysts to reach some USD 35 billion by 2023. Targovax at Redeye’s Fight Cancer event 20th of September:. Listing on the Oslo Axess. Phone: 47 21 39 88 10.

investors.taubman.com

Q4 Web Site Development

Q4 Web Maintenance Message. This site is currently under development and not yet available for public viewing. For more information on why this site is not available, please contact Q4.

investors.taylormorrison.com

Taylor Morrison (NYSE - TMHC) Investor Relations - Investors

Previous Close $20.10. 52 Week High $21.40. 52 Week Low $14.96. Taylor Morrison Reports Second Quarter Revenue of $701 Million and Adjusted Earnings per Share of $0.33. Taylor Morrison has been helping families create memories for more than a century. We are proud to instill this deep heritage into every new home we build, helping to make us one of the leading homebuilders in the United States. Our long-term strategy is built upon the following FOUR PILLARS. Culture of Strong Cost Efficiency. Data provid...